comparemela.com

Latest Breaking News On - Avdl - Page 1 : comparemela.com

Avadel Pharmaceuticals (AVDL) to Release Quarterly Earnings on Wednesday

Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) will issue its quarterly earnings data before the market opens on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.25) per share for the quarter. Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) last posted its quarterly earnings data on Monday, March 4th. The company reported […]

Head-To-Head Comparison: Avadel Pharmaceuticals (NASDAQ:AVDL) vs RedHill Biopharma (NASDAQ:RDHL)

Avadel Pharmaceuticals (NASDAQ:AVDL – Get Free Report) and RedHill Biopharma (NASDAQ:RDHL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation. Profitability This table compares Avadel Pharmaceuticals and […]

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Recommendation of Buy by Brokerages

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average rating of “Buy” from the seven research firms that are currently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have updated their coverage on the […]

Avadel Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVDL)

Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders purchased 5,250 put options on the company. This represents an increase of approximately 324% compared to the typical volume of 1,239 put options. Insider Buying and Selling at Avadel Pharmaceuticals In related news, CFO Thomas […]

Brokerages Set Avadel Pharmaceuticals plc (NASDAQ:AVDL) Target Price at $19 86

Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have updated their coverage on the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.